Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.12e-22	114	140	20	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	6.61e-22	124	140	20	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	5.29e-21	137	140	20	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	5.08e-18	192	140	20	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 ADAMTS13 USP17L19 NPEPL1 F7 USP17L18 USP17L17 TPP1 USP17L6P USP17L22 MYRF USP17L15 USP17L8 USP17L13	4.17e-12	654	140	25	GO:0008233
GeneOntologyMolecularFunction	alkaline phosphatase activity	ALPI ALPL ALPP ALPG	3.43e-08	6	140	4	GO:0004035
GeneOntologyMolecularFunction	N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity	CHSY1 CHPF2 CHPF	1.34e-06	4	140	3	GO:0050510
GeneOntologyMolecularFunction	glucuronosyltransferase activity	CHSY1 UGT1A4 UGT1A3 CHPF2 CHPF	4.32e-06	35	140	5	GO:0015020
GeneOntologyMolecularFunction	glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity	CHSY1 CHPF2 CHPF	6.64e-06	6	140	3	GO:0047238
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.00e-20	125	138	19	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.62e-19	144	138	19	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L7 USP17L21 USP17L4 NEURL2 USP17L2 USP17L12 USP17L1 USP17L20 TRIM35 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 FBXL3 MEFV USP17L18 RFPL4B ASB18 ISG15 USP17L17 ASB16 DTX4 USP17L6P UHRF1 USP17L22 UHRF2 TRIM38 USP17L15 USP17L8 USP17L13	6.76e-13	1009	138	31	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L7 USP17L21 USP17L4 NEURL2 USP17L2 USP17L12 USP17L1 USP17L20 TRIM35 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 FBXL3 MEFV USP17L18 RFPL4B ASB18 ISG15 USP17L17 ASB16 DTX4 USP17L6P UHRF1 USP17L22 UHRF2 TRIM38 USP17L15 USP17L8 USP17L13	3.42e-12	1074	138	31	GO:0043687
GeneOntologyBiologicalProcess	coenzyme A catabolic process	ALPI ALPP ALPG	2.39e-05	9	138	3	GO:0015938
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 COPB1 USP17L20 USP17L11 RDH12 USP17L5 TMTC2 USP17L10 TMEM43 USP17L19 USP17L18 UGT1A4 UGT1A3 USP17L17 PI4KB SLC27A1 GUCY2D USP17L6P USP17L22 MYRF USP17L15 NOTCH3 USP17L8 USP17L13	8.49e-09	1293	141	29	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 COPB1 USP17L20 USP17L11 RDH12 USP17L5 TMTC2 USP17L10 TMEM43 USP17L19 USP17L18 UGT1A4 UGT1A3 USP17L17 PI4KB SLC27A1 GUCY2D USP17L6P USP17L22 MYRF USP17L15 NOTCH3 USP17L8 USP17L13	9.41e-09	1299	141	29	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 COPB1 USP17L20 USP17L11 RDH12 USP17L5 TMTC2 USP17L10 TMEM43 USP17L19 USP17L18 UGT1A4 UGT1A3 USP17L17 PI4KB SLC27A1 GUCY2D USP17L6P USP17L22 MYRF USP17L15 NOTCH3 USP17L8 USP17L13	1.51e-08	1327	141	29	GO:0042175
MousePheno	increased trophectoderm apoptosis	USP17L2 USP17L15 USP17L13	1.46e-05	8	91	3	MP:0012119
Domain	HABP4_PAI-RBP1	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	6.03e-26	16	138	13	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	6.03e-26	16	138	13	IPR006861
Domain	UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	1.56e-21	71	138	17	PF00443
Domain	USP_2	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	1.56e-21	71	138	17	PS00973
Domain	USP_3	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	2.03e-21	72	138	17	PS50235
Domain	USP_dom	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	2.03e-21	72	138	17	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	2.03e-21	72	138	17	IPR001394
Domain	USP_CS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	2.02e-20	66	138	16	IPR018200
Domain	USP_1	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L8 USP17L13	5.71e-20	70	138	16	PS00972
Domain	Alk_phosphatase	ALPI ALPL ALPP ALPG	2.85e-09	4	138	4	PF00245
Domain	Alkaline_phosphatase_AS	ALPI ALPL ALPP ALPG	2.85e-09	4	138	4	IPR018299
Domain	Alkaline_phosphatase	ALPI ALPL ALPP ALPG	2.85e-09	4	138	4	IPR001952
Domain	alkPPc	ALPI ALPL ALPP ALPG	2.85e-09	4	138	4	SM00098
Domain	ALKALINE_PHOSPHATASE	ALPI ALPL ALPP ALPG	2.85e-09	4	138	4	PS00123
Domain	Chond_GalNAc	CHSY1 CHPF2 CHPF	2.15e-05	8	138	3	IPR008428
Domain	CHGN	CHSY1 CHPF2 CHPF	2.15e-05	8	138	3	PF05679
Domain	PRY	TRIM35 BTN2A1 MEFV RFPL4B TRIM38	2.72e-05	48	138	5	SM00589
Domain	PRY	TRIM35 BTN2A1 MEFV RFPL4B TRIM38	2.72e-05	48	138	5	IPR006574
Domain	ConA-like_dom	TRIM35 LAMA3 NBEA BTN2A1 MEFV RFPL4B PTPRM CSPG4 TRIM38	3.68e-05	219	138	9	IPR013320
Domain	TMEM183	TMEM183A TMEM183BP	5.42e-05	2	138	2	IPR026509
Domain	YDG	UHRF1 UHRF2	5.42e-05	2	138	2	PS51015
Domain	TTD	UHRF1 UHRF2	5.42e-05	2	138	2	PF12148
Domain	Rrp44_S1	DIS3L DIS3	5.42e-05	2	138	2	PF17215
Domain	SAD_SRA	UHRF1 UHRF2	5.42e-05	2	138	2	PF02182
Domain	SRA	UHRF1 UHRF2	5.42e-05	2	138	2	SM00466
Domain	-	UHRF1 UHRF2	5.42e-05	2	138	2	2.30.280.10
Domain	RRP44_S1	DIS3L DIS3	5.42e-05	2	138	2	IPR033770
Domain	TTD_dom	UHRF1 UHRF2	5.42e-05	2	138	2	IPR021991
Domain	SRA_YDG	UHRF1 UHRF2	5.42e-05	2	138	2	IPR003105
Domain	Alkaline_phosphatase_core	ALPI ALPL ALPP ALPG	7.69e-05	31	138	4	IPR017850
Domain	Alkaline_Pase-like_a/b/a	ALPI ALPL ALPP ALPG	7.69e-05	31	138	4	IPR017849
Domain	-	ALPI ALPL ALPP ALPG	7.69e-05	31	138	4	3.40.720.10
Domain	RIBOSOMAL_S4E	RPS4X RPS4Y1	1.62e-04	3	138	2	PS00528
Domain	Ribosomal_S4e_central_region	RPS4X RPS4Y1	1.62e-04	3	138	2	IPR013845
Domain	Ribosomal_S4e_N	RPS4X RPS4Y1	1.62e-04	3	138	2	IPR013843
Domain	Ribosomal_S4e_central	RPS4X RPS4Y1	1.62e-04	3	138	2	PD002667
Domain	RIBONUCLEASE_II	DIS3L DIS3	1.62e-04	3	138	2	PS01175
Domain	40S_S4_C	RPS4X RPS4Y1	1.62e-04	3	138	2	PF16121
Domain	Rrp44_CSD1	DIS3L DIS3	1.62e-04	3	138	2	PF17216
Domain	40S_S4_C	RPS4X RPS4Y1	1.62e-04	3	138	2	IPR032277
Domain	Ribosomal_S4e_N_CS	RPS4X RPS4Y1	1.62e-04	3	138	2	IPR018199
Domain	RS4NT	RPS4X RPS4Y1	1.62e-04	3	138	2	PF08071
Domain	Rrp44_CSD1	DIS3L DIS3	1.62e-04	3	138	2	IPR033771
Domain	Ribosomal_S4e	RPS4X RPS4Y1	1.62e-04	3	138	2	IPR000876
Domain	CAF1C_H4-bd	GRWD1 RBBP7	1.62e-04	3	138	2	PF12265
Domain	Ribosomal_S4e	RPS4X RPS4Y1	1.62e-04	3	138	2	PF00900
Domain	Histone-bd_RBBP4_N	GRWD1 RBBP7	1.62e-04	3	138	2	IPR022052
Domain	Butyrophylin	TRIM35 BTN2A1 MEFV RFPL4B TRIM38	1.69e-04	70	138	5	IPR003879
Domain	PRY	TRIM35 BTN2A1 MEFV TRIM38	2.57e-04	42	138	4	PF13765
Domain	RNase_II/R_CS	DIS3L DIS3	3.22e-04	4	138	2	IPR022966
Domain	S4	RPS4X RPS4Y1	3.22e-04	4	138	2	PF01479
Domain	SPRY	TRIM35 BTN2A1 MEFV RFPL4B TRIM38	4.66e-04	87	138	5	SM00449
Domain	S4	RPS4X RPS4Y1	5.34e-04	5	138	2	SM00363
Domain	S4	RPS4X RPS4Y1	5.34e-04	5	138	2	PS50889
Domain	SPRY	TRIM35 BTN2A1 MEFV RFPL4B TRIM38	6.64e-04	94	138	5	PF00622
Domain	SPRY_dom	TRIM35 BTN2A1 MEFV RFPL4B TRIM38	6.64e-04	94	138	5	IPR003877
Domain	B30.2/SPRY	TRIM35 BTN2A1 MEFV RFPL4B TRIM38	6.97e-04	95	138	5	IPR001870
Domain	B302_SPRY	TRIM35 BTN2A1 MEFV RFPL4B TRIM38	6.97e-04	95	138	5	PS50188
Domain	S4_RNA-bd	RPS4X RPS4Y1	7.97e-04	6	138	2	IPR002942
Domain	Cadherin-like	DSG1 DAG1 PCDHAC1 PCDH15 CDH3	1.70e-03	116	138	5	IPR015919
Domain	SOCS_box	NEURL2 ASB18 ASB16	2.76e-03	38	138	3	PF07525
Domain	KOW	RPS4X RPS4Y1	2.85e-03	11	138	2	IPR005824
Domain	KOW	RPS4X RPS4Y1	2.85e-03	11	138	2	PF00467
Domain	SOCS_box	NEURL2 ASB18 ASB16	2.97e-03	39	138	3	SM00969
Domain	SOCS_box	NEURL2 ASB18 ASB16	2.97e-03	39	138	3	IPR001496
Domain	SOCS	NEURL2 ASB18 ASB16	2.97e-03	39	138	3	PS50225
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.62e-27	45	111	18	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	8.38e-15	191	111	18	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L8 USP17L13	1.40e-12	221	111	17	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.99e-12	262	111	18	MM15286
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L7 TPR USP17L21 NRIP1 USP17L4 NEURL2 USP17L2 USP17L12 USP17L1 COPB1 APOA5 RBBP7 USP17L20 USP17L11 AMDHD2 DAG1 MUC16 USP17L5 USP17L10 ADAMTS13 USP17L19 F7 FBXL3 USP17L18 ASB18 USP17L17 ASB16 USP17L6P USP17L22 UHRF2 USP17L15 ALPI ALPL USP17L8 ALPP DNMT1 ALPG USP17L13	2.08e-12	1389	111	38	MM15307
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 KSR2 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	5.39e-12	318	111	19	MM15278
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L8 USP17L13	1.71e-10	299	111	17	M27574
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	TPR USP17L21 NRIP1 USP17L4 NEURL2 USP17L2 USP17L12 USP17L1 COPB1 APOA5 RBBP7 USP17L20 USP17L11 USP17L24 AMDHD2 DAG1 MUC16 USP17L5 USP17L10 ADAMTS13 USP17L19 F7 FBXL3 USP17L18 ASB18 USP17L17 ASB16 USP17L22 UHRF2 USP17L15 ALPI ALPL USP17L8 DNMT1 ALPG USP17L13	2.56e-10	1475	111	36	M19806
Pathway	KEGG_FOLATE_BIOSYNTHESIS	ALPI ALPL ALPP ALPG	1.15e-06	11	111	4	M2220
Pathway	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	CHSY1 CSPG4 CHPF2 CHPF	1.29e-05	19	111	4	MM14800
Pathway	REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	CHSY1 CSPG4 CHPF2 CHPF	1.60e-05	20	111	4	M658
Pathway	REACTOME_DIGESTION	SI ALPI ALPP ALPG	1.97e-05	21	111	4	MM15526
Pathway	KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS	CHSY1 CHPF2 CHPF	2.59e-05	8	111	3	M47920
Pathway	REACTOME_DIGESTION_AND_ABSORPTION	SI ALPI ALPP ALPG	4.05e-05	25	111	4	MM15557
Pathway	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	CHSY1 CSPG4 CHPF2 CHPF	5.43e-04	48	111	4	MM14696
Pathway	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	CHSY1 CSPG4 CHPF2 CHPF	6.34e-04	50	111	4	M678
Pathway	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	CHSY1 CHPF2 CHPF	6.56e-04	22	111	3	M19166
Pathway	REACTOME_DISEASES_OF_METABOLISM	DAG1 CHSY1 MUC16 SI ADAMTS13 UGT1A4 CSPG4 NOTCH3	8.02e-04	250	111	8	M27554
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	DAG1 CHSY1 MUC16 ADAMTS13 CSPG4 NOTCH3	9.28e-04	143	111	6	M27275
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.27e-41	21	142	18	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.27e-41	21	142	18	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.27e-41	21	142	18	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.27e-41	21	142	18	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.27e-41	21	142	18	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.27e-41	21	142	18	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.34e-40	22	142	18	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.28e-39	24	142	18	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.52e-38	25	142	18	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.93e-38	26	142	18	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	9.04e-38	33	142	19	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.04e-37	34	142	19	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.45e-37	35	142	19	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.45e-37	35	142	19	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	9.39e-37	36	142	19	20147298
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.08e-36	29	142	18	32527007
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.92e-36	37	142	19	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	5.25e-31	50	142	18	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L15 USP17L8	1.93e-15	10	142	7	24207026
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L15 USP17L8 DNMT1	4.60e-15	19	142	8	28067227
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L15 USP17L8	1.27e-14	12	142	7	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L15 USP17L8	5.46e-14	14	142	7	11793228
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 BTN2A1 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	4.45e-11	674	142	19	37196079
Pubmed	Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia.	ALPI ALPL ALPP ALPG	2.66e-10	4	142	4	9056646
Pubmed	Structural evidence of functional divergence in human alkaline phosphatases.	ALPI ALPL ALPP ALPG	2.66e-10	4	142	4	12372831
Pubmed	Stage-specific expression patterns of alkaline phosphatase during development of the first arch skeleton in inbred C57BL/6 mouse embryos.	ALPI ALPL ALPP ALPG	2.66e-10	4	142	4	9061447
Pubmed	TNAP limits TGF-β-dependent cardiac and skeletal muscle fibrosis by inactivating the SMAD2/3 transcription factors.	CSPG4 ALPI ALPL ALPP ALPG	8.18e-10	12	142	5	31289197
Pubmed	Central role of pyrophosphate in acellular cementum formation.	ALPI ALPL ALPP ALPG	1.33e-09	5	142	4	22675556
Pubmed	Two alkaline phosphatase genes are expressed during early development in the mouse embryo.	ALPI ALPL ALPP ALPG	1.33e-09	5	142	4	2133555
Pubmed	Germ cell nuclear antigen (GCNA1) expression does not require a gonadal environment or steroidogenic factor 1: examination of GCNA1 in ectopic germ cells and in Ftz-F1 null mice.	ALPI ALPL ALPP ALPG	1.33e-09	5	142	4	9291464
Pubmed	Dissection of the odontoblast differentiation process in vitro by a combination of FGF1, FGF2, and TGFbeta1.	ALPI ALPL ALPP ALPG	3.97e-09	6	142	4	10878613
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 PCDHAC1 USP17L19 USP17L18 USP17L17	3.39e-08	119	142	8	28625976
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L15 USP17L8	4.40e-08	81	142	7	12838346
Pubmed	Organic pyrophosphates as substrates for human alkaline phosphatases.	ALPI ALPP ALPG	6.66e-08	3	142	3	16742561
Pubmed	The defect seen in the phosphatidylinositol hydrolysis pathway in HIV-infected lymphocytes and lymphoblastoid cells is due to inhibition of the inositol 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesterase.	ALPI ALPL ALPP	6.66e-08	3	142	3	1321014
Pubmed	Two gene duplication events in the evolution of the human heat-stable alkaline phosphatases.	ALPI ALPP ALPG	6.66e-08	3	142	3	3443302
Pubmed	Role of lysophosphatidylcholine in brush-border intestinal alkaline phosphatase release and restoration.	ALPI ALPP ALPG	6.66e-08	3	142	3	19407215
Pubmed	Genomic structure and comparison of mouse tissue-specific alkaline phosphatase genes.	ALPI ALPP ALPG	6.66e-08	3	142	3	2286375
Pubmed	Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels.	ALPI ALPP ALPG	6.66e-08	3	142	3	27106638
Pubmed	Effects of disruption of the embryonic alkaline phosphatase gene on preimplantation development of the mouse.	ALPI ALPP ALPG	6.66e-08	3	142	3	10767088
Pubmed	MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice.	ALPI ALPP ALPG	6.66e-08	3	142	3	11722850
Pubmed	A novel phosphatase upregulated in Akp3 knockout mice.	ALPI ALPP ALPG	6.66e-08	3	142	3	17901166
Pubmed	Interactions between CD36 and global intestinal alkaline phosphatase in mouse small intestine and effects of high-fat diet.	ALPI ALPP ALPG	2.66e-07	4	142	3	21900644
Pubmed	Novel Role of the ALPI Gene Associated with Constipation Caused by Complement Component 3 Deficiency.	ALPI ALPP ALPG	2.66e-07	4	142	3	39273477
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	2.66e-07	4	142	3	22984479
Pubmed	Chondroitin synthases I, II, III and chondroitin sulfate glucuronyltransferase expression in colorectal cancer.	CHSY1 CHPF2 CHPF	2.66e-07	4	142	3	21468578
Pubmed	Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN).	DSG1 RPS4X USP17L24 LAMA3 BAZ1A DNMT1	2.82e-07	65	142	6	32120844
Pubmed	Dnmt1 is essential to maintain progenitors in the perinatal intestinal epithelium.	ALPI ALPP DNMT1 ALPG	1.23e-06	20	142	4	26023099
Pubmed	M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability.	UHRF1 UHRF2 DNMT1	1.32e-06	6	142	3	22411829
Pubmed	Hydrolysis and absorption of pantothenate and its coenzymes in the rat small intestine.	ALPI ALPP ALPG	1.32e-06	6	142	3	6619987
Pubmed	Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice.	SI ALPI ALPP ALPG	2.22e-06	23	142	4	24680895
Pubmed	Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters.	ALPI ALPP ALPG	2.30e-06	7	142	3	26831517
Pubmed	S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.	UHRF1 UHRF2 DNMT1	2.30e-06	7	142	3	22064703
Pubmed	Chondroitin sulfate N-acetylgalactosaminyltransferase-1 plays a critical role in chondroitin sulfate synthesis in cartilage.	CHSY1 CHPF2 CHPF	2.30e-06	7	142	3	17145758
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	BMP6 CSPG4 PKD1 NOTCH3 ALPI ALPL ALPP ALPG	2.59e-06	210	142	8	16537572
Pubmed	Biosynthesis of chondroitin sulphate by a Golgi-apparatus-enriched preparation from cultures of mouse mastocytoma cells.	CHSY1 CHPF2 CHPF	3.68e-06	8	142	3	6781479
Pubmed	A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation.	ALPI ALPP ALPG	5.50e-06	9	142	3	21324897
Pubmed	Functional Proteomic Analysis of Repressive Histone Methyltransferase Complexes Reveals ZNF518B as a G9A Regulator.	RBBP7 NOC3L BAZ1A UHRF1 DNMT1	6.14e-06	63	142	5	25680957
Pubmed	Multimodal spatiotemporal transcriptomic resolution of embryonic palate osteogenesis.	ALPI ALPP ALPG	7.83e-06	10	142	3	37709732
Pubmed	IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus.	ALPI ALPP ALPG	1.07e-05	11	142	3	37703370
Pubmed	Postnatal lethality and chondrodysplasia in mice lacking both chondroitin sulfate N-acetylgalactosaminyltransferase-1 and -2.	CHSY1 CHPF2 CHPF	1.43e-05	12	142	3	29287114
Pubmed	A YY1-dependent increase in aerobic metabolism is indispensable for intestinal organogenesis.	ALPI ALPP ALPG	1.43e-05	12	142	3	27802136
Pubmed	Purification and partial sequencing of human placental alkaline phosphatase.	ALPP ALPG	1.66e-05	2	142	2	6651840
Pubmed	Lenvatinib inhibited HCC cell migration and invasion through regulating the transcription and ubiquitination of UHRF1 and DNMT1.	UHRF1 DNMT1	1.66e-05	2	142	2	36893815
Pubmed	Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.	UGT1A4 UGT1A3	1.66e-05	2	142	2	24641623
Pubmed	A Molecular Tool Targeting the Base-Flipping Activity of Human UHRF1.	UHRF1 DNMT1	1.66e-05	2	142	2	31322780
Pubmed	Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for a substrate specificity.	ALPP ALPG	1.66e-05	2	142	2	11124260
Pubmed	Products of two common alleles at the locus for human placental alkaline phosphatase differ by seven amino acids.	ALPP ALPG	1.66e-05	2	142	2	3461452
Pubmed	Characterization of alkaline phosphatase genes expressed in seminoma by cDNA cloning.	ALPL ALPG	1.66e-05	2	142	2	9823315
Pubmed	Expression of different-sized placental alkaline phosphatase mRNAs in placenta and choriocarcinoma cells.	ALPP ALPG	1.66e-05	2	142	2	3459156
Pubmed	Site-specific mutations in the COOH-terminus of placental alkaline phosphatase: a single amino acid change converts a phosphatidylinositol-glycan-anchored protein to a secreted protein.	ALPP ALPG	1.66e-05	2	142	2	1730777
Pubmed	Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA.	ALPP ALPG	1.66e-05	2	142	2	3001717
Pubmed	Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization.	CHSY1 CHPF	1.66e-05	2	142	2	12716890
Pubmed	Placental and intestinal alkaline phosphatases are receptors for Aeromonas sobria hemolysin.	ALPI ALPP	1.66e-05	2	142	2	15715171
Pubmed	The DNA methyltransferase Dnmt1 directly interacts with the SET and RING finger-associated (SRA) domain of the multifunctional protein Uhrf1 to facilitate accession of the catalytic center to hemi-methylated DNA.	UHRF1 DNMT1	1.66e-05	2	142	2	24253042
Pubmed	Chemical nature of intestinal-type alkaline phosphatase in human kidney.	ALPI ALPL	1.66e-05	2	142	2	1458595
Pubmed	Nucleotide sequence of the human placental alkaline phosphatase gene. Evolution of the 5' flanking region by deletion/substitution.	ALPP ALPG	1.66e-05	2	142	2	3042787
Pubmed	Aspartic acid-484 of nascent placental alkaline phosphatase condenses with a phosphatidylinositol glycan to become the carboxyl terminus of the mature enzyme.	ALPP ALPG	1.66e-05	2	142	2	3422741
Pubmed	UHRF1 plays a role in maintaining DNA methylation in mammalian cells.	UHRF1 DNMT1	1.66e-05	2	142	2	17673620
Pubmed	A possible 5'-NRIP1/UHRF1-3' fusion gene detected by array CGH analysis in a Ph+ ALL patient.	NRIP1 UHRF1	1.66e-05	2	142	2	22285022
Pubmed	Mutation of a single amino acid converts germ cell alkaline phosphatase to placental alkaline phosphatase.	ALPP ALPG	1.66e-05	2	142	2	1939159
Pubmed	Human placental and intestinal alkaline phosphatase genes map to 2q34-q37.	ALPI ALPP	1.66e-05	2	142	2	3687940
Pubmed	Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells.	UHRF1 DNMT1	1.66e-05	2	142	2	37247564
Pubmed	Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.	APOA5 BTN2A1	1.66e-05	2	142	2	22576629
Pubmed	Tandem virtual screening targeting the SRA domain of UHRF1 identifies a novel chemical tool modulating DNA methylation.	UHRF1 DNMT1	1.66e-05	2	142	2	27049577
Pubmed	Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup.	TMEM183A TMEM183BP	1.66e-05	2	142	2	16644869
Pubmed	Modifications in a flexible surface loop modulate the isozyme-specific properties of mammalian alkaline phosphatases.	ALPL ALPP	1.66e-05	2	142	2	8244974
Pubmed	UHRF genes regulate programmed interdigital tissue regression and chondrogenesis in the embryonic limb.	UHRF1 UHRF2	1.66e-05	2	142	2	31024001
Pubmed	Reversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1.	UHRF1 DNMT1	1.66e-05	2	142	2	25189999
Interaction	FLT3 interactions	USP17L21 GRWD1 USP17L12 USP17L20 USP17L11 PCDHAC1 DDX56 USP17L19 USP17L18 USP17L17 BAZ1A DNAJC9	1.58e-06	318	135	12	int:FLT3
Cytoband	4p16.1	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.83e-23	79	142	15	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.56e-16	222	142	15	chr4p16
Cytoband	8p23.1	USP17L7 USP17L4 USP17L2 USP17L1 MFHAS1 SPAG11B USP17L8	5.67e-07	154	142	7	8p23.1
Cytoband	2q37	UGT1A4 UGT1A3 ALPP ALPG	2.59e-06	31	142	4	2q37
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 USP17L4 USP17L2 USP17L1 MFHAS1 SPAG11B USP17L8	9.06e-06	234	142	7	chr8p23
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	UGT1A4 UGT1A3 ASB18 ALPI ALPP ALPG	7.80e-05	226	142	6	chr2q37
GeneFamily	Alkaline phosphatases	ALPI ALPL ALPP ALPG	6.00e-10	4	91	4	1072
GeneFamily	Beta 4-glycosyltransferases	CHSY1 CHPF2 CHPF	7.97e-05	17	91	3	425
GeneFamily	Beta 3-glycosyltransferases	CHSY1 CHPF2 CHPF	2.31e-04	24	91	3	426
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	SIN3B RBBP7	8.82e-04	9	91	2	1306
GeneFamily	Exosome complex	DIS3L DIS3	1.60e-03	12	91	2	817
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	SIN3B RBBP7	1.60e-03	12	91	2	1243
GeneFamily	WD repeat domain containing	GRWD1 RBBP7 NBEA WDR87 STRN4 WDR45B	2.09e-03	262	91	6	362
GeneFamily	Ring finger proteins	TRIM35 RFPL4B DTX4 UHRF1 UHRF2 TRIM38	2.65e-03	275	91	6	58
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	3.97e-24	86	139	18	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	6.58e-22	112	139	18	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 NR1D1 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.79e-20	160	139	19	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 UGT1A3 USP17L17 TPP1 SLC27A1 DNAJC9 USP17L6P PLEC USP17L22 USP17L15 USP17L8 USP17L13	5.43e-13	647	139	23	MM981
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 TCIRG1 USP17L5 USP17L10 USP17L19 USP17L18 UGT1A4 UGT1A3 NOP9 ISG15 PTPRM USP17L17 TPP1 SLC27A1 DNAJC9 USP17L6P PLEC USP17L22 USP17L15 USP17L8 USP17L13	5.12e-11	1226	139	28	MM979
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L7 TPR USP17L21 SIN3B TCF4 USP17L4 DDAH1 USP17L2 TMEM183A USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 TMEM183BP USP17L19 USP17L18 PTPRM USP17L17 PKD1 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	8.26e-10	1198	139	26	MM1062
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L7 USP17L21 NRIP1 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 NR1D1 MEFV USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	2.36e-07	1072	139	21	MM1031
Coexpression	GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	SIN3B PPRC1 MUC16 TMTC2 NBEA SLC7A4	1.77e-05	102	139	6	M6681
Coexpression	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	SIN3B RPS4X RPS4Y1 NBEA C8G	4.39e-05	73	139	5	MM1304
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_200	ITGA8 MUC16 CDH3 MYRF	1.79e-05	28	120	4	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_200
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ST7 EPB41L5 LAMA3 TMTC2 TACC2 PTPRM ALPL	2.20e-06	199	132	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Club_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	RPS4Y1 TENT5C BMP6 GRHL1 NOTCH3 ALPG	8.33e-06	160	132	6	b261a3a49c850d92bc9e04fc3527c752dfe37a1a
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPB41L5 LAMA3 ASB16 MYRF ALPP ALPG	1.14e-05	169	132	6	cd16e8462ee09877be962fbd9a3badcb825820b0
ToppCell	368C-Epithelial_cells-Epithelial-B_(AT2)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	SDK2 DDAH1 LAMA3 TACC2 GUCY2D CDH3	1.48e-05	177	132	6	ac8f774596068e66c0a9ea8a318be0ce5f5df834
ToppCell	368C-Epithelial_cells-Epithelial-B_(AT2)\|368C / Donor, Lineage, Cell class and subclass (all cells)	SDK2 DDAH1 LAMA3 TACC2 GUCY2D CDH3	1.48e-05	177	132	6	d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe
ToppCell	AT1_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	EPB41L5 LAMA3 ALS2CL SLC7A4 MYRF ALPP	1.58e-05	179	132	6	1603117b52623663458a977c94bf7f9f6c1114b8
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ADAMTS13 ALS2CL GRHL1 CDH3	1.76e-05	108	132	5	9c7f3e25facfb54ef0be45044999bc36438bbea0
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ADAMTS13 ALS2CL GRHL1 CDH3	1.76e-05	108	132	5	75d635fc5bb004418db2e1328c24d96b718f10b1
ToppCell	Control-Epithelial-ATI\|World / Disease state, Lineage and Cell class	EPB41L5 LAMA3 TACC2 ALS2CL MYRF ALPP	1.90e-05	185	132	6	0563d5042bb96ecce8446fbf26d05ef7a45e23c5
ToppCell	droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPB41L5 NR1D1 F7 SPAG11B DTX4 UHRF1	1.90e-05	185	132	6	b4af9ae4c358b48357cb135b740266e1652d886a
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 ITGA8 NBEA CSPG4 ANKDD1A NOTCH3	2.02e-05	187	132	6	d591a3c216997663ab77710fed0d230ffc37e41a
ToppCell	Control-Epithelial-ATI\|Control / Disease state, Lineage and Cell class	EPB41L5 LAMA3 TACC2 ALS2CL MYRF ALPP	2.02e-05	187	132	6	fdd1c57b61ca9392ac27661a82729f37593df63c
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 ITGA8 NBEA CSPG4 ANKDD1A NOTCH3	2.02e-05	187	132	6	d1dc8c9a2c2cd10c640257161a75e7730ec5bb41
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 ITGA8 NBEA CSPG4 ANKDD1A NOTCH3	2.02e-05	187	132	6	ac8e092b37e042975e2ee057d3f7c6821e58e8b5
ToppCell	Mesenchymal_cells-Ng2+_MSCs\|Mesenchymal_cells / Lineage and Cell class	PODNL1 SDK2 ALS2CL F7 TNS3 ALPL	2.02e-05	187	132	6	e899b906409f3fad69cb3d3c6432c3fd862ae3c1
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	TCF4 ITGA8 CHSY1 BMP6 PTPRM PCDH15	2.14e-05	189	132	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	LAM-Epithelial-AT1\|LAM / Condition, Lineage and Cell class	DDAH1 EPB41L5 LAMA3 MYRF ALPP ALPG	2.27e-05	191	132	6	66875b2ec2c510489407f3e433a90cdf74a15094
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PODNL1 MXRA5 SGCG ITGA8 F7 ALPL	2.27e-05	191	132	6	98b907f8fa024cf32e462323b782c5a371327bbd
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPB41L5 LAMA3 TMTC2 TACC2 PTPRM ALPL	2.48e-05	194	132	6	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SGCG SPEG ITGA8 TACC2 CSPG4 NOTCH3	2.55e-05	195	132	6	56e7cd980f8fc2dae842e6a7bd919d4b41cebbbb
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPB41L5 LAMA3 TMTC2 TACC2 PTPRM ALPL	2.55e-05	195	132	6	9406866f99555198a9be311fbd65751b70f35446
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SGCG SPEG ITGA8 TACC2 CSPG4 NOTCH3	2.55e-05	195	132	6	a28a504c69bc4dda7de023e1b4ea4f62390b158e
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SIN3B EPB41L5 GRHL1 PLAC8L1 DTX4 ALPP	2.63e-05	196	132	6	d5f9168001e60bafec17fe6c702e68f5528edc20
ToppCell	droplet-Heart-HEART-1m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG ITGA8 NR1D1 CSPG4 CHPF NOTCH3	2.63e-05	196	132	6	1eb14182ef26e6141f510d397b00bf8a12efda3e
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SGCG SPEG ITGA8 TACC2 CSPG4 NOTCH3	2.63e-05	196	132	6	4740ef6e428f1ccc81fc98c3b868afd38ce60535
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KSR2 TACC2 SLC7A4 UHRF1 CDH3 MYRF	2.70e-05	197	132	6	49689a03ab31e53386dbe15c77c09ca3a14ebf4e
ToppCell	AT1-AT2_cells\|World / lung cells shred on cell class, cell subclass, sample id	DDAH1 EPB41L5 LAMA3 ALS2CL MYRF ALPP	2.78e-05	198	132	6	a5b3617ea2ed4bffba59edcf6284799c2b3bbb29
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DDAH1 ST7 EPB41L5 LAMA3 TMTC2 TACC2	2.86e-05	199	132	6	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	EPB41L5 LAMA3 TACC2 ALS2CL MYRF ALPP	2.86e-05	199	132	6	aca81a879ef9c196bd1885eff4c63ffe6c9682b7
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PODNL1 MXRA5 CSPG4 NOTCH3 TNS3 ALPL	2.94e-05	200	132	6	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	Neuronal-Inhibitory-iA\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TCF4 SLC10A4 ITGA8 LAMA3 BMP6 PTPRM	2.94e-05	200	132	6	5ef4a3dc18a44292184a59ced916183c0699b01e
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	RPS4Y1 BAZ1A NFIC DNAJC9 UHRF1 DNMT1	2.94e-05	200	132	6	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	RPS4Y1 BAZ1A NFIC DNAJC9 UHRF1 DNMT1	2.94e-05	200	132	6	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_only / Treatment groups by lineage, cell group, cell type	SLC10A4 ITGA8 NBEA CSPG4 NOTCH3 TNS3	2.94e-05	200	132	6	69edc375d85689300d1dbc1217fedc40063ecdcb
ToppCell	356C-Epithelial_cells-Epithelial-E_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	FAM178B PLAC8L1 C8G ALPP ALPG	6.33e-05	141	132	5	31e0984f09983e83a814424f74c871c1c5a3a789
ToppCell	356C-Epithelial_cells-Epithelial-E_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	FAM178B PLAC8L1 C8G ALPP ALPG	6.33e-05	141	132	5	d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Platelets-Platelets\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM178B RDH12 SI SPAG6 GUCY2D	9.02e-05	152	132	5	aff7d1127ef72be489477611c4decc53cc7632e3
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Platelets\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM178B RDH12 SI SPAG6 GUCY2D	9.02e-05	152	132	5	0a99c91165e4d82fb8825fbdf3071c9a5445669d
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SGCG SPEG ADAMTS13 PKD1 CHPF	1.05e-04	157	132	5	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LAMA3 GRHL1 DTX4 GUCY2D CDH3	1.08e-04	158	132	5	98712ed7e8e65e8c5ff9318cf0e0a04e271a055d
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF4 DDAH1 SLC10A4 LAMA3 NBEA	1.18e-04	161	132	5	3b5d7a3dab479c6959a428f3954dedd989900276
ToppCell	COVID-CD8-memory_CD4\|COVID / Condition, Cell_class and T cell subcluster	IFT22 NR1D1 PKD1 DNAJC9 CHPF	1.22e-04	162	132	5	22b2a32217d357146c117e618813d451510a1801
ToppCell	P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TCAF2 ITGA8 NR1D1 ALDH16A1 KRTCAP3	1.44e-04	168	132	5	8c8dbdbc7053f34e4ca0c5067af502fbea109fc1
ToppCell	356C-Epithelial_cells-Epithelial-E_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	DDAH1 LAMA3 PLAC8L1 ALPP ALPG	1.52e-04	170	132	5	4cd3b7e43a061948084c01713ae141b5c2c07d89
ToppCell	356C-Epithelial_cells-Epithelial-E_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	DDAH1 LAMA3 PLAC8L1 ALPP ALPG	1.52e-04	170	132	5	36c9f7f98612a72dc511c8da4358d67444f6bcf4
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	EPB41L5 LAMA3 TACC2 MYRF ALPG	1.65e-04	173	132	5	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 ITGA8 PCDHAC1 ANKDD1A NOTCH3	1.75e-04	175	132	5	1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f
ToppCell	AT1-AT2_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	LAMA3 ALS2CL SLC7A4 CDH3 MYRF	1.75e-04	175	132	5	9a95ab5c361ebaa8747983c5a0d69025682a19ad
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SDK2 ITGA8 ADAMTS13 SLC7A4 GRHL1	1.75e-04	175	132	5	c227fc5d1ccb69b82a96a6354913cafaf27d0eec
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCIRG1 F7 BAZ1A UHRF1 DNMT1	1.79e-04	176	132	5	270d7908dbd84028958d257f94941dc685e20255
ToppCell	10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PODNL1 MXRA5 MYRF NOTCH3 ALPL	1.89e-04	178	132	5	8f31b3fac51591f7f2bcb898c07708b3e9f93a16
ToppCell	droplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5C NBEA CHPF TNS3 ALPL	1.89e-04	178	132	5	b902059c3f861108fc64cbdc05e6f44378f5be2c
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	EPB41L5 LAMA3 TACC2 ALS2CL MYRF	1.94e-04	179	132	5	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	LAMA3 CDH3 MYRF ALPP ALPG	1.94e-04	179	132	5	d5763912a4ce7188535675e338799b856edb9dda
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	SPEG ITGA8 LAMA3 CSPG4 NOTCH3	1.94e-04	179	132	5	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPB41L5 LAMA3 TACC2 MYRF TNS3	1.94e-04	179	132	5	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBEA ADAMTS13 NR1D1 ALS2CL GUCY2D	1.94e-04	179	132	5	dd94ebe69ade6f51b94058abe066216f0de9feda
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COPB1 LAMA3 NBEA BMP6 PTPRM	1.99e-04	180	132	5	baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c
ToppCell	AT1_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	EPB41L5 LAMA3 ALS2CL MYRF ALPP	1.99e-04	180	132	5	2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCIRG1 NR1D1 F7 BAZ1A NCKAP1L	1.99e-04	180	132	5	cc31d2cd06161300b91b17a67bb432b75f0d719b
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COPB1 LAMA3 NBEA BMP6 PTPRM	1.99e-04	180	132	5	2d608b9394d28d19cfc85c6ac94003d5177c8a92
ToppCell	droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REM1 ITGA8 LIN7B CSPG4 NOTCH3	1.99e-04	180	132	5	78fdcfb3fdbf36469cae78407cda5bd0996930d8
ToppCell	droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGCG SPEG ITGA8 CSPG4 NOTCH3	1.99e-04	180	132	5	b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COPB1 LAMA3 NBEA BMP6 PTPRM	1.99e-04	180	132	5	0f9b27054358c4737eed06c8ea01987cccc3cb55
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MXRA5 REM1 ALS2CL CSPG4 NOTCH3	2.04e-04	181	132	5	634a4f4e5942473e60d08d0b0936407b04bc6b7c
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MXRA5 REM1 ALS2CL CSPG4 NOTCH3	2.04e-04	181	132	5	c2938cf1f5d4875be07a56a1f36c94f8eab37d99
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPB41L5 LAMA3 MYRF TNS3 ALPI	2.04e-04	181	132	5	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	Pericytes-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	REM1 FAM178B ITGA8 CSPG4 NOTCH3	2.04e-04	181	132	5	ff445a8e56522e57e27405184d123cf905caf8cc
ToppCell	AT1-AT2_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	EPB41L5 LAMA3 ALS2CL MYRF ALPP	2.04e-04	181	132	5	ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3
ToppCell	(2)_5-FU-(4)_COL2.3+_osteoblasts\|(2)_5-FU / Stress and Cell class	TENT5C TMTC2 NR1D1 PKD1 ALPL	2.04e-04	181	132	5	56ae86072858c156681507aecd1bc6cb0a3372d2
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCIRG1 NR1D1 F7 BAZ1A NCKAP1L	2.09e-04	182	132	5	94d061b7b5ebbfc564c644bc8b2d52341927145d
ToppCell	COPD-Epithelial-ATI\|World / Disease state, Lineage and Cell class	EPB41L5 LAMA3 TACC2 ALS2CL MYRF	2.09e-04	182	132	5	e95d946a43b1579af199900bb0e3eacbb9d65300
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EPB41L5 LAMA3 TACC2 ALS2CL MYRF	2.15e-04	183	132	5	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SDK2 ZBTB17 CSPG4 CDH3 NOTCH3	2.15e-04	183	132	5	0e8fb371d8eac777451c76f41d53577f5dfb740d
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	EPB41L5 LAMA3 TACC2 ALS2CL MYRF	2.15e-04	183	132	5	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR1D1 F7 SPAG11B CSPG4 UHRF1	2.15e-04	183	132	5	42dc31d587fbb9724b2f0be5ee8ed77233f67b86
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SDK2 ZBTB17 CSPG4 CDH3 NOTCH3	2.15e-04	183	132	5	cbc3b00faa7e4e0dbbbc8ee105467c65241c7470
ToppCell	Pericytes-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	REM1 SPEG ITGA8 CSPG4 NOTCH3	2.20e-04	184	132	5	cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)\|367C / Donor, Lineage, Cell class and subclass (all cells)	DDAH1 TACC2 GUCY2D KRTCAP3 ALPL	2.20e-04	184	132	5	0ba243cbf69b4fe6ae100a7f0314317bec38026c
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPB41L5 LAMA3 TMTC2 ALS2CL MYRF	2.20e-04	184	132	5	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	(2)_5-FU-(4)_COL2.3+_osteoblasts\|World / Stress and Cell class	TENT5C TMTC2 NR1D1 PKD1 ALPL	2.20e-04	184	132	5	684d05340a3dfb8aa08b881516a37f9627a10448
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	LAMA3 TMTC2 ALS2CL MYRF ALPP	2.20e-04	184	132	5	cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	LAMA3 TMTC2 ALS2CL MYRF ALPP	2.20e-04	184	132	5	bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	EPB41L5 LAMA3 TACC2 ALS2CL MYRF	2.20e-04	184	132	5	561592edc3083fad41b91811151b442207c65dd9
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	DDAH1 TACC2 GUCY2D KRTCAP3 ALPL	2.20e-04	184	132	5	2a8338e94937686a148b5433515700ca0f674058
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPB41L5 LAMA3 TMTC2 ALS2CL MYRF	2.20e-04	184	132	5	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR1D1 F7 SPAG11B UHRF1 DNMT1	2.20e-04	184	132	5	16aa8e88bdd51b1d132d5cf33c29963b384a8bae
ToppCell	droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REM1 ITGA8 LIN7B CSPG4 NOTCH3	2.20e-04	184	132	5	f4344f3c407b2d4d703fe56e43d84dbfe60ba833
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SDK2 ADAMTS13 CSPG4 CDH3 NOTCH3	2.26e-04	185	132	5	a6cd90f8f30c7bdf66958cf403e73c193aa32f5e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	EPB41L5 LAMA3 TMTC2 ALS2CL MYRF	2.26e-04	185	132	5	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TCAF2 TCF4 PDE8A ITGA8 WDR45B	2.26e-04	185	132	5	673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SDK2 ADAMTS13 CSPG4 CDH3 NOTCH3	2.26e-04	185	132	5	5053f932e2adfcf4d6faaecff2999ac53d8d7aa5
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC10A4 LAMA3 BMP6 PTPRM PCDH15	2.32e-04	186	132	5	310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCell	COPD-Epithelial-ATI\|COPD / Disease state, Lineage and Cell class	EPB41L5 LAMA3 TACC2 ALS2CL MYRF	2.32e-04	186	132	5	df0977f6f48a2d4e11b59971f098b01204242f0f
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	TENT5C NBEA BMP6 GRHL1 NOTCH3	2.37e-04	187	132	5	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGCG SPEG ITGA8 CSPG4 NOTCH3	2.37e-04	187	132	5	59313a47a6012b2413d7d3673bb05fb7e49fd88f
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	REM1 GRWD1 KSR2 DAG1 NOTCH3	2.37e-04	187	132	5	69b47f00598d647e2a99427ebddf42c339428e47
ToppCell	droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGCG SPEG ITGA8 CSPG4 NOTCH3	2.37e-04	187	132	5	2591fe1552cd10925ad1d8d1f062a057ce6bdad9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 ITGA8 CSPG4 ANKDD1A NOTCH3	2.37e-04	187	132	5	15d6e158562d7d85af3ceaf955439b379c8fce81
ToppCell	367C-Epithelial_cells-Epithelial-E_(AT2)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	DDAH1 TACC2 GUCY2D KRTCAP3 ALPL	2.37e-04	187	132	5	11670a85db87cbb3e78022a589632173604b0940
Drug	5-hydroxycytidine	ALPI ALPL ALPP	1.65e-07	3	126	3	CID000198207
Drug	Alphostatin	ALPI ALPL ALPP	1.65e-07	3	126	3	CID000174788
Drug	BIAP	ALPI ALPL ALPP ALPG	2.86e-07	11	126	4	CID005487027
Drug	AttoPhos	ALPI ALPL ALPP ALPG	2.86e-07	11	126	4	CID000188920
Drug	paricalcitol	UGT1A4 UGT1A3 ALPI ALPL ALPP	6.11e-07	30	126	5	CID005281104
Drug	3-indoxyl phosphate	ALPI ALPL ALPP	6.59e-07	4	126	3	CID000026292
Drug	ammediol	ALPI ALPL ALPP	6.59e-07	4	126	3	CID000001531
Drug	p-bromotetramisole	ALPI ALPL ALPP	6.59e-07	4	126	3	CID000005121
Drug	ethylethanolamine	ALPI ALPL ALPP	6.59e-07	4	126	3	CID000008072
Drug	SMR 6	ALPI ALPL ALPP	1.64e-06	5	126	3	CID006439864
Drug	ranelic acid	ALPI ALPL ALPP	1.64e-06	5	126	3	CID003052774
Drug	Fast Blue RR	ALPI ALPL ALPP	1.64e-06	5	126	3	CID000093116
Drug	mitomycin phosphate	ALPI ALPL ALPP	1.64e-06	5	126	3	CID000130219
Drug	5-fluorosalicylic acid	ALPI ALPL ALPP	3.27e-06	6	126	3	CID000067658
Drug	FADP	ALPI ALPL ALPP	3.27e-06	6	126	3	CID003081481
Drug	ethoxyquin	UGT1A4 UGT1A3 PLEC UHRF2 ALPI ALPL ALPP	3.80e-06	116	126	7	CID000003293
Drug	p-aminodiphenylamine	ALPI ALPL ALPP	5.70e-06	7	126	3	CID000007564
Drug	fosfosal	ALPI ALPL ALPP	9.08e-06	8	126	3	CID000003418
Drug	orellanine	ALPI ALPL ALPP	9.08e-06	8	126	3	CID000089579
Drug	iopentol	ALPI ALPL ALPP	9.08e-06	8	126	3	CID000056016
Drug	(1S,2E,3S)-2-[(2E)-2-[(7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-3-methyl-cyclohexanol	ALPI ALPL ALPP	9.08e-06	8	126	3	CID011953890
Drug	Aphos	ALPI ALPL ALPP	1.36e-05	9	126	3	CID000053051
Drug	naphthol AS-TR	ALPI ALPL ALPP	1.36e-05	9	126	3	CID000066718
Drug	aminohexane	ALPI ALPL ALPP	1.36e-05	9	126	3	CID000201427
Drug	phenolphthalein monophosphate	ALPI ALPL ALPP	1.36e-05	9	126	3	CID000128862
Drug	fosfluconazole	ALPI ALPL ALPP	1.36e-05	9	126	3	CID000214356
Drug	urochloralic acid	UGT1A4 UGT1A3 ALPI ALPL ALPP	1.89e-05	59	126	5	CID003036914
Drug	naphthol AS-MX	ALPI ALPL ALPP	1.93e-05	10	126	3	CID000066717
Drug	photobiotin	ALPI ALPL ALPP	1.93e-05	10	126	3	CID003035428
Drug	AC1Q6S3P	DDX56 ALPI ALPL ALPP ALPG	2.61e-05	63	126	5	CID000000665
Drug	855 sigma	ALPI ALPL ALPP	2.64e-05	11	126	3	CID000074136
Drug	forphenicine	ALPI ALPL ALPP	2.64e-05	11	126	3	CID000042560
Drug	4-aminophenyl phosphate	ALPI ALPP	3.04e-05	2	126	2	CID000122270
Drug	fast red violet LB salt	ALPI ALPP	3.04e-05	2	126	2	CID006370075
Drug	afloqualone	UGT1A4 UGT1A3	3.04e-05	2	126	2	ctd:C033541
Drug	3-(hydroxymethyl)phenytoin	ALPI ALPP	3.04e-05	2	126	2	ctd:C043104
Drug	5-bromo-4-chloroindoxyl	ALPI ALPP	3.04e-05	2	126	2	CID009964843
Drug	AC1L48S9	ALPI ALPL ALPP	3.51e-05	12	126	3	CID000152644
Drug	2-amino-2-methyl-1-propanol	ALPI ALPL ALPP	3.51e-05	12	126	3	CID000011807
Drug	Meldola	UGT1A4 UGT1A3 ALPI ALPL ALPP	3.78e-05	68	126	5	CID000081507
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	DSG1 UGT1A4 UGT1A3 PLEC	4.10e-05	35	126	4	CID010436171
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NRIP1 ZBTB17 GRWD1 PPRC1 BAZ1A NFIC TNS3	4.25e-05	168	126	7	6820_DN
Drug	AMPPD	ALPI ALPL ALPP	4.55e-05	13	126	3	CID000064599
Drug	AC1L38JC	ALPI ALPL ALPP	4.55e-05	13	126	3	CID000084962
Drug	ferrous lactate	ALPI ALPL ALPP	4.55e-05	13	126	3	CID000022197
Drug	deltoin	TCF4 F7 ALPI ALPL ALPP	4.66e-05	71	126	5	CID000021908
Drug	1 alpha OHD2	ALPI ALPL ALPP	5.76e-05	14	126	3	CID004479094
Drug	ELF-97	ALPI ALPL ALPP	5.76e-05	14	126	3	CID000132799
Drug	MDPC	PLEC ALPI ALPL ALPP	6.33e-05	39	126	4	CID000032842
Drug	7,8-dihydro-D-neopterin	DDX56 ALPI ALPL ALPP ALPG	6.47e-05	76	126	5	CID000000659
Drug	aluminum nitride	SGCG ALPI ALPL ALPP	7.00e-05	40	126	4	CID000090455
Drug	Etopophos	ALPI ALPL ALPP	7.17e-05	15	126	3	CID000060668
Drug	BCIP	ALPI ALPL ALPP ALPG	7.73e-05	41	126	4	CID000065409
Drug	C-S-S	SPEG CHSY1 NOP9 CHPF2 ALPG	8.27e-05	80	126	5	CID000165331
Drug	AC1MRHRO	KCNH6 ALPI ALPL ALPP	9.34e-05	43	126	4	CID003468412
Drug	ipriflavone	NRIP1 ALPI ALPL ALPP	1.12e-04	45	126	4	CID000003747
Drug	Evoxine [522-11-2]; Up 200; 11.6uM; HL60; HT_HG-U133A	TCF4 REM1 ITGA8 NR1D1 PTPRM CHPF ALPL	1.16e-04	197	126	7	2186_UP
Drug	purmorphamine	BMP6 ALPI ALPP	1.27e-04	18	126	3	CID005284329
Drug	phenolphthalein diphosphate	ALPI ALPL ALPP	1.27e-04	18	126	3	CID000074975
Drug	naphthol AS	ALPI ALPL ALPP	1.50e-04	19	126	3	CID000066719
Drug	calcium lactate pentahydrate	ALPI ALPL ALPP	1.50e-04	19	126	3	CID000165341
Drug	norethisterone acetate	F7 ALPI ALPL ALPP	1.69e-04	50	126	4	CID000005832
Drug	a-carotene	TCF4 APOA5 LAMA3	1.76e-04	20	126	3	CID000024090
Drug	lead phosphate	ALPI ALPL ALPP	1.76e-04	20	126	3	CID000024009
Drug	dimyristoylphosphatidic acid	ALPI ALPL ALPP	1.76e-04	20	126	3	CID000093134
Drug	F-Ct	REM1 NOP9 NFIC	1.76e-04	20	126	3	CID000445968
Drug	Fast Blue RR Base	ALPI ALPP	1.81e-04	4	126	2	CID000080442
Drug	Sb15	ALPI ALPP	1.81e-04	4	126	2	CID000044950
Drug	naphthol AS phosphate	ALPI ALPP	1.81e-04	4	126	2	CID000084137
Drug	beta-naphthyl phosphate	ALPI ALPL ALPP	2.05e-04	21	126	3	CID000083133
Drug	tetramisole	DAG1 ALPI ALPL ALPP ALPG	2.06e-04	97	126	5	CID000003913
Drug	tangeretin	MEFV UGT1A4 UGT1A3 ALPL	2.28e-04	54	126	4	CID000068077
Drug	amonafide	UGT1A4 UGT1A3 CDH3	2.36e-04	22	126	3	CID000050515
Drug	naphthol AS-BI phosphate	ALPI ALPL ALPP	2.36e-04	22	126	3	CID000074715
Drug	gamma-carboxyglutamic acid	F7 NFIC ALPI ALPL ALPP	2.48e-04	101	126	5	CID000040772
Drug	3-hydroxyandrostan-17-one	NRIP1 MEFV UGT1A4 UGT1A3 GRHL1	2.60e-04	102	126	5	CID000000225
Drug	dean	ALPI ALPL ALPP	2.70e-04	23	126	3	CID000008113
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.92e-33	46	131	19	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L8 USP17L13	1.96e-29	69	131	19	DOID:1682 (implicated_via_orthology)
Disease	Autosomal recessive limb-girdle muscular dystrophy	SGCG DAG1 PLEC	3.00e-05	14	131	3	cv:C2931907
Disease	tissue factor measurement	F7 UGT1A4 UGT1A3	1.07e-04	21	131	3	EFO_0010623
Disease	Carcinoma, Pancreatic Ductal	DTX4 NOTCH3 DNMT1	1.62e-04	24	131	3	C0887833
Disease	Limb-girdle muscular dystrophy	SGCG DAG1 PLEC	2.06e-04	26	131	3	cv:C0686353
Disease	cerebral infarction (is_implicated_in)	APOA5 F7 MYRF	2.87e-04	29	131	3	DOID:3526 (is_implicated_in)
Disease	alkaline phosphatase measurement, liver enzyme measurement	ADAMTS13 ALPL	2.90e-04	6	131	2	EFO_0004533, EFO_0004582
Disease	Muscular Dystrophies, Limb-Girdle	SGCG DAG1 PLEC	3.86e-04	32	131	3	C0686353
Disease	pulse pressure measurement	NRIP1 TCF4 MXRA5 DDAH1 PDE8A MFHAS1 PCDHAC1 NBEA ZCCHC2 BMP6 ANKDD1A PKD1 UHRF1 NOTCH3 TNS3 DNMT1	4.60e-04	1392	131	16	EFO_0005763
Disease	X-11793--oxidized bilirubin measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0021260
Disease	Succinimide measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0022118
Disease	X-11530 measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0021249
Disease	sulfate of piperine metabolite C16H19NO3 (2) measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0801034
Disease	cholelithiasis, bilirubin measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0004570, EFO_0004799
Disease	X-11522 measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0800696
Disease	X-10458 measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0800692
Disease	X-24849 measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0800909
Disease	Retinal Dystrophies	PODNL1 RDH12	5.38e-04	8	131	2	C0854723
Disease	membrane-associated progesterone receptor component 1 measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0802740
Disease	X-16946 measurement	UGT1A4 UGT1A3	5.38e-04	8	131	2	EFO_0800766
Disease	refractive error	NRIP1 KSR2 NBEA GUCY2D MYRF ALPP ALPG	6.53e-04	326	131	7	MONDO_0004892
Disease	X-11442 measurement	UGT1A4 UGT1A3	6.90e-04	9	131	2	EFO_0021236
Disease	X-11441 measurement	UGT1A4 UGT1A3	6.90e-04	9	131	2	EFO_0021235
Disease	circulating cell free DNA measurement	UGT1A4 UGT1A3	6.90e-04	9	131	2	EFO_0004739
Disease	sulfate of piperine metabolite C18H21NO3 (3) measurement	UGT1A4 UGT1A3	6.90e-04	9	131	2	EFO_0801037
Disease	sulfate of piperine metabolite C18H21NO3 (1) measurement	UGT1A4 UGT1A3	6.90e-04	9	131	2	EFO_0801036
Disease	X-11880 measurement	UGT1A4 UGT1A3	6.90e-04	9	131	2	EFO_0800698
Disease	protein-tyrosine kinase 6 measurement	UGT1A4 UGT1A3	6.90e-04	9	131	2	EFO_0020691
Disease	testis-specific chromodomain protein Y 1 measurement	UGT1A4 UGT1A3	6.90e-04	9	131	2	EFO_0802127
Disease	bilirubin measurement, response to xenobiotic stimulus	UGT1A4 UGT1A3	6.90e-04	9	131	2	EFO_0004570, GO_0009410
Disease	bilirubin measurement, response to tenofovir	UGT1A4 UGT1A3	8.60e-04	10	131	2	EFO_0004570, EFO_0009279
Disease	X-21448 measurement	UGT1A4 UGT1A3	8.60e-04	10	131	2	EFO_0800816
Disease	UDP-glucuronosyltransferase 1-6 measurement	UGT1A4 UGT1A3	8.60e-04	10	131	2	EFO_0802185
Disease	X-23974 measurement	UGT1A4 UGT1A3	8.60e-04	10	131	2	EFO_0800867
Disease	histidine betaine (hercynine) measurement	UGT1A4 UGT1A3	1.05e-03	11	131	2	EFO_0800972
Disease	X-21796 measurement	UGT1A4 UGT1A3	1.05e-03	11	131	2	EFO_0800825
Disease	insomnia, bilirubin measurement	UGT1A4 UGT1A3	1.05e-03	11	131	2	EFO_0004570, EFO_0004698
Disease	aldosterone measurement	UGT1A4 UGT1A3	1.05e-03	11	131	2	EFO_0010219
Disease	p-cresol glucuronide measurement	UGT1A4 UGT1A3	1.25e-03	12	131	2	EFO_0800079
Disease	biliverdin measurement	UGT1A4 UGT1A3	1.25e-03	12	131	2	EFO_0021033
Disease	developmental disorder of mental health (implicated_via_orthology)	SIN3B TCF4 NCKAP1L	1.36e-03	49	131	3	DOID:0060037 (implicated_via_orthology)
Disease	Leber congenital amaurosis (implicated_via_orthology)	RDH12 GUCY2D	1.48e-03	13	131	2	DOID:14791 (implicated_via_orthology)
Disease	retinol dehydrogenase 16 measurement	UGT1A4 UGT1A3	1.48e-03	13	131	2	EFO_0802007
Disease	hepcidin:ferritin ratio	TACC2 ALPI ALPP	1.90e-03	55	131	3	EFO_0007901
Disease	Leber congenital amaurosis	RDH12 GUCY2D	2.25e-03	16	131	2	cv:C0339527
Disease	diacylglycerol 36:2 measurement	APOA5 MYRF	2.25e-03	16	131	2	EFO_0010355
Disease	Dementia	NOTCH3 DNMT1	2.55e-03	17	131	2	C0497327
Disease	low density lipoprotein cholesterol measurement, body fat percentage	UGT1A4 UGT1A3	2.55e-03	17	131	2	EFO_0004611, EFO_0007800
Disease	Disorder of eye	RDH12 TPP1 GUCY2D PCDH15 CDH3	2.61e-03	212	131	5	C0015397
Disease	urolithiasis	ALPI ALPL ALPP	2.80e-03	63	131	3	MONDO_0024647
Disease	angiopoietin-related protein 1 measurement	UGT1A4 UGT1A3	2.86e-03	18	131	2	EFO_0801382
Disease	glucose homeostasis measurement, acute insulin response measurement	SDK2 PTPRM	2.86e-03	18	131	2	EFO_0006831, EFO_0006896
Disease	diacylglycerol 36:3 measurement	APOA5 MYRF	2.86e-03	18	131	2	EFO_0020062
Disease	familial hyperlipidemia (biomarker_via_orthology)	F7 SLC27A1	3.18e-03	19	131	2	DOID:1168 (biomarker_via_orthology)
Disease	platelet crit	NRIP1 NOC3L EPB41L5 DAG1 TENT5C BMP6 NFIC ANKDD1A PLEC CDH3 NOTCH3	3.52e-03	952	131	11	EFO_0007985
Disease	Deaf Mutism	TMTC2 PCDH15	3.53e-03	20	131	2	C4082305
Disease	Deafness, Acquired	TMTC2 PCDH15	3.53e-03	20	131	2	C0751068
Disease	Hearing Loss, Extreme	TMTC2 PCDH15	3.53e-03	20	131	2	C0086395
Disease	Complete Hearing Loss	TMTC2 PCDH15	3.53e-03	20	131	2	C0581883
Disease	Bilateral Deafness	TMTC2 PCDH15	3.53e-03	20	131	2	C3665473
Disease	Prelingual Deafness	TMTC2 PCDH15	3.53e-03	20	131	2	C0011052
Disease	dilated cardiomyopathy	ZBTB17 PKD1	3.53e-03	20	131	2	EFO_0000407
Disease	muscular dystrophy (implicated_via_orthology)	SGCG DAG1	3.89e-03	21	131	2	DOID:9884 (implicated_via_orthology)
Disease	Leber Congenital Amaurosis	RDH12 GUCY2D	4.26e-03	22	131	2	C0339527

Protein segments in the cluster

Peptide	Gene	Start	Entry
LHARGHQAVVLTPEV	UGT1A3	51	P35503
IGEHHPTRELVVNAV	ALS2CL	176	Q60I27
QGHRAEATTLHVAPQ	C8G	66	P07360
DGQPHEVSVHINAHR	CSPG4	281	Q6UVK1
DHAPVQTISRIFHVA	CSPG4	1016	Q6UVK1
QGRVLHPEQHRVVSV	DNMT1	1536	P26358
HPGVVRAQHLTRLAE	ALDH16A1	96	Q8IZ83
ETPLHVAAARGLEQH	ASB16	211	Q96NS5
GIGRHVQELHRSVAP	APOA5	201	Q6Q788
VFAHVHPRTQVPVAG	SLC7A4	356	O43246
VSHHIEAVVRAGPRA	DTX4	26	Q9Y2E6
VAPHARIAIHALATN	ADAMTS13	1331	Q76LX8
TRHSHGPLQADVFVE	BAZ1A	1336	Q9NRL2
EFPAKAVGEHLARQH	TFAP2D	311	Q7Z6R9
VNHFGAHVRRPVGAL	SLC10A4	126	Q96EP9
APARVVNVSSVAHHI	RDH12	166	Q96NR8
EHITKIPNEAAHRGT	MUC16	10431	Q8WXI7
LIRDPFGHHVARNVA	NOP9	591	Q86U38
IAHAVLQLPTREAHA	OR52W1	226	Q6IF63
AFTASEGHAHPRVVE	LIN7B	81	Q9HAP6
HVVEGNFRHASSRAP	LAMA3	1586	Q16787
HVDQRPFVGHTRSVE	GRWD1	251	Q9BQ67
RVPHAVVCIVGTHAD	MFHAS1	526	Q9Y4C4
AAVARHIRDAQVPGF	GUCY2D	376	Q02846
VASAEHPRGSVHEQL	PPP1R2P1	26	Q96PQ5
TPLHVAAQRGLDEHA	ASB18	221	Q6ZVZ8
IGVHAFQQRLAVHPS	ISG15	36	P05161
AIHVLRNHAVGPSTA	TCF4	396	P15884
FQLGHRVDEAHTPKA	KSR2	316	Q6VAB6
TNDEVVSHPRRIAVH	KCNH6	326	Q9H252
PEAGVARGIDFHHVS	DDX56	341	Q9NY93
SAVDAFEIHVHRRPQ	DAG1	586	Q14118
VHLDIAAPVHAGERA	NPEPL1	461	Q8NDH3
IAATIHDVDHPGRTN	PDE8A	591	O60658
HQGPDAAVTGHIRIR	COPB1	916	P53618
TQHHLVAADIRVAPA	NOTCH3	1751	Q9UM47
DVRNSTQHLGPVHRE	NCKAP1L	66	P55160
IRDRFAESPHHVGQS	NRIP1	211	P48552
SQEHQGHRVRPIEEV	MEFV	401	O15553
AGAIHANTHLERIPA	RFPL4B	186	Q6ZWI9
VVHRFAGHVSPLINV	OR51A2	261	Q8NGJ7
FHRVHGANIRVDPSG	NEURL2	26	Q9BR09
VHVHDNRPASNVVVT	DSG1	851	Q02413
RDVHVVEFHRQSPAK	ITGA8	906	P53708
QPHHVLSRASVGAAA	OXER1	196	Q8TDS5
NHLVVARVHIPNDDA	RBBP7	76	Q16576
VAVFARGPQAHLVHG	ALPI	456	P09923
RHRFHVHPKSGEVQV	PCDHAC1	281	Q9H158
PHNHVAALGARDLVA	PODNL1	366	Q6PEZ8
VFARGPQAHLVHGVQ	ALPP	461	P05187
VAVFARGPQAHLVHG	ALPG	456	P10696
AVPLRHETHGGEDVA	ALPL	446	P05186
HIPGFRDLSQHDQVT	NR1D1	456	P20393
ELVVVATDGAVHPRH	PCDH15	786	Q96QU1
AVEHHAFFRLRGPVQ	EPB41L5	316	Q9HCM4
AHGVVIVFNADIPSH	IFT22	81	Q9H7X7
DVHFANLQRGTHVLP	GRHL1	476	Q9NZI5
RIDVVSENPGQTHFH	FBXL3	256	Q9UKT7
LGVHIADVTHFVAPN	DIS3L	501	Q8TF46
VVTRDGVHVHPRAAG	BMP6	331	P22004
VPEEGLTLHRVGTHQ	BTN2A1	511	Q7KYR7
HKVSLQVHPDRVGEG	DNAJC9	36	Q8WXX5
HQSVSHGEAAVIRAP	SDK2	121	Q58EX2
AVRLQEGVHGPSRVH	PPRC1	1276	Q5VV67
HVPENAVGHEVQRLT	CDH3	336	P22223
HPAAFGRATHAVVRA	DDAH1	6	O94760
ARPGEHDLNHTVFQV	C14orf178	66	Q8N769
GAVLHGTVLRHVANP	KRTCAP3	36	Q53RY4
PRVGDHVVSVRGKNH	PKD1	1941	P98161
ENGVHRHGPIQVEFV	PTPRM	1301	P28827
RTHQADHVPIILVGN	REM1	181	O75628
HPIVQRFAAHLIAGA	NOC3L	701	Q8WTT2
DGHAHIVELLVRNGA	GABPB2	81	Q8TAK5
GHRVQPVKDTAHDFR	TRIM35	131	Q9UPQ4
ERAPQHKGHTTALVE	TRIM38	116	O00635
SIHSVAPENEGRLVH	TMEM43	76	Q9BTV4
GQIGRHTPEHARAVA	SPAG6	361	O75602
VHETVLGIPRAQAHE	TCAF2	786	A6NFQ2
EDEHFISNLRGHVPA	PLAC8L1	31	A1L4L8
HHRVRLVFQDSPVHG	TMEM183BP	326	Q1AE95
PHRVFVTQEEAHGVL	F7	41	P08709
QEVREAFHSLGAHSP	FAM178B	371	Q8IXR5
APRAVLTGHDHEVVC	NBEA	2771	Q8NFP9
GVIRRVSQLFHEHPD	SIN3B	81	O75182
TNRERHPGSFDVVHV	RPS4Y1	196	P22090
HGTVHIFAAEDPKRN	WDR45B	251	Q5MNZ6
TNRERHPGSFDVVHV	RPS4X	196	P62701
AHVFGETVARPVLHE	SI	706	P14410
NAVEAIHRAVEFNPH	ST7	401	Q9NRC1
HVVPAQVHVNGDAAL	TNS3	456	Q68CZ2
QHHRPVIAVHSGIAR	NFIC	351	P08651
TAGFDHHVVRVPHTQ	PI4KB	371	Q9UBF8
QVHISHREARGPSFR	SPAG11B	71	Q08648
EVGVHIADVSHFIRP	DIS3	501	Q9Y2L1
PRGVHIQAHAGKIEA	SGCG	206	Q13326
ALHRQVHAAATPDLG	REPIN1	101	Q9BWE0
HEVLTEVVPIHGRGN	TENT5C	26	Q5VWP2
VVDHQGASPLHLAVR	ANKDD1A	286	Q495B1
RSQEVGVVHVHHPVF	CHSY1	736	Q86X52
VQEGDPHFRSALTAH	CHPF	311	Q8IZ52
LAVAVNRTVAHHFPR	CHPF2	116	Q9P2E5
TVAPHRAQREAVHIE	ZCCHC2	341	Q9C0B9
FRVQVSEAGVHRPHV	UHRF2	461	Q96PU4
TFVGHQQRIHTGERP	ZNF549	346	Q6P9A3
HVIQPSQALAAGFHR	USP17L4	141	A6NCW7
HHRVRLVFQDSPVHG	TMEM183A	326	Q8IXX5
DVHRLVFPAVGPQHA	SPEG	1241	Q15772
HQRAGHTIPRIFQAV	SLC27A1	71	Q6PCB7
VVPHRTDGFAEAIHS	TPR	2141	P12270
HPIHTEAVAGIVGRA	TMTC2	126	Q8N394
HVIQPSQALAAGFHR	USP17L18	141	D6R9N7
HVIQPSQALAAGFHR	USP17L5	141	A8MUK1
HVIQPSQALAAGFHR	USP17L21	141	D6R901
HVIQPSQALAAGFHR	USP17L13	141	C9JLJ4
HVIQPSQALAAGFHR	USP17L19	141	D6RCP7
VERAAAFQVAPHSHG	TACC2	1571	O95359
HVIQPSQALAAGFHR	USP17L1	141	Q7RTZ2
QIATGGVIDPVHSHR	PLEC	2946	Q15149
HVIQPSQALAAGFHR	USP17L12	141	C9JPN9
RFRVQVSESGVHRPH	UHRF1	431	Q96T88
FADPGALQRHVRIHT	ZBTB17	511	Q13105
HVIQPSQALAAGFHR	USP17L24	141	Q0WX57
HVIQPSQVLAAGFHR	USP17L7	141	P0C7H9
HVIQPSQALAAGFHR	USP17L8	141	P0C7I0
NAALDVEPIHAFRAH	STRN4	476	Q9NRL3
DTLVQHQRFHTGERP	ZNF304	376	Q9HCX3
HVIQPSQALAAGFHR	USP17L6P	141	Q6QN14
HVIQPSQALAAGFHR	USP17L22	141	D6RA61
HVIQPSQALAAGFHR	USP17L15	141	C9J2P7
HVIQPSQALAAGFHR	USP17L17	141	D6RBQ6
VNNRAIAFDHSVPHV	WDR87	696	Q6ZQQ6
NSFILHQRVHTGERP	ZNF584	311	Q8IVC4
HVIQPSQALAAGFHR	USP17L23	141	D6RBM5
LTQHQRVHTGERPFE	ZNF583	311	Q96ND8
HVIQPSQALAAGFHR	USP17L2	141	Q6R6M4
VLRQGHEPQLAAAHT	TCIRG1	131	Q13488
HVIQPSQALAAGFHR	USP17L20	141	D6RJB6
HVIQPSQALAAGFHR	USP17L10	141	C9JJH3
HVIQPSQALAAGFHR	USP17L11	141	C9JVI0
QALAPHVDFVGGLHR	TPP1	161	O14773
LHARGHQAVVLTPEV	UGT1A4	51	P22310
DGRVHASHQLTRVPA	MXRA5	1596	Q9NR99
AHRAHPQGLVLVTDA	AMDHD2	281	Q9Y303
QRAQVPDTVFHHGRV	MYRF	546	Q9Y2G1